Navigation Links
Organizers of cancer clinical trials are neglecting teenagers and young adults
Date:6/9/2008

-24 years in all three years. In 2005/6, 42.6% of 10-14 year olds with cancer were recruited to clinical trials, 22.9% of 15-19 year-olds and 13.4% of 20-24 year-olds. In 2006/7, there were slight increases in accrual rates for 15-19 year olds (41.3% aged 10-14, 27.3% aged 15-19), but a drop for 20-24 year-olds to 10.9%. Dr Fern expressed concern that these trends would continue as analysis of the 2007/08 data suggested that recruitment of 20-24 year olds has fallen to approximately 7.5%, compared to 39.7% of 10-14 year olds and 25.4% of 15-19 years.

She said: "There are a number of reasons for the low level of recruitment of teenagers and young adults to trials, particularly for the 20-24 year-olds. These include inappropriate trial design, poor accessibility to trials for TYAs, and too many young people not being treated by specialist cancer teams.

"At present, the design and age eligibility criteria for trials tend to reflect whether the trial organisers treat children or adult patients, rather than the biology of the particular cancer, and the age group which it is mostly likely to occur in. Traditionally, trials will have an age cut off between 16 and 20. TYAs are constantly falling through the gap created by the tendency for paediatricians to treat the younger ages, and for the older ages to be treated in adult cancer wards.

"If we are to see improvements in the treatments and outcomes for TYAs with cancer, there needs to be closer dialogue between research groups when they are planning cancer trials. They should give particular consideration to the specific needs of this over-looked age group so that a more appropriate trial portfolio for TYAs can be established in the UK."

Dr Fern said she thought that particular effort was needed to improve the recruitment of 20-24 year-olds to clinical trials. "One of the reasons why there is a relatively higher level of 10-14 year-olds entering trials is because they tend to be treat
'/>"/>

Contact: Emma Mason
wordmason@mac.com
44-077-112-96986
Teenage Cancer Trust
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Ortho Organizers(R) Introduces New Premium Product Line - O2 Select(TM) Orthodontic Instruments
2. Ortho Organizers(R) Introduces Product Line Extension - Rectangular Super Elastic Nitanium(R) Black Ti(TM) Archwire
3. Ortho Organizers(R) Announces the Launch of the Ancor Pro(TM) Orthodontic Anchorage System Hands-on Course
4. Pill box organizers increase HIV patients adherence and improve viral suppression
5. Poor sleep a problem in long-term breast cancer survivors
6. Women worrying about cancer are more likely to experience sleep disturbances
7. SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Italy
8. Family history and screening for colorectal cancer
9. Teenagers and young adults with cancer can face long delays before finally being diagnosed
10. Young patient waited ten months before being diagnosed with cancer
11. Blood Cancer Drug Shows Promise Against Lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... ... 2015 , ... Displays and Exhibits , a top online retailer of ... all purchases that include branding. Enter price code brand2015 for a ten percent discount ... packaging and promotional materials, all should integrate the company logo to communicate the brand. ...
(Date:6/29/2015)... Wethersfield, CT (PRWEB) , ... June 29, 2015 ... ... their centers recognized by the independent auditor of customer service for the 40-center ... of more than 1,100 skilled nursing centers in the United States in one ...
(Date:6/29/2015)... ... June 29, 2015 , ... Assurex Health, a precision medicine ... and chronic pain conditions, has announced appointments to three key leadership roles, according ... Senior Vice President, Chief Financial Officer; Craig S. Lewis, Senior Vice President, Chief ...
(Date:6/29/2015)... ... June 29, 2015 , ... New ... that fewer than 10 percent of U.S. state and local governments have implemented ... an implementation deadline for NG9-1-1. , “Mobile phones have surpassed land lines ...
(Date:6/29/2015)... ... 29, 2015 , ... Blue Cross and Blue Shield of ... Markets division, which includes the company’s commercial health plan portfolio of products and ... and international reach. Mary Ellen Anderson now holds the title of vice president, ...
Breaking Medicine News(10 mins):Health News:Stock Up on Logo Branding Tools Reduced this Month and Next Month from Displays and Exhibits 2Health News:National HealthCare Centers Receive 'Customer Experience Awards' 2Health News:National HealthCare Centers Receive 'Customer Experience Awards' 3Health News:National HealthCare Centers Receive 'Customer Experience Awards' 4Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 2Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 3Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 2Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 3Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 4Health News:Blue Cross and Blue Shield of Minnesota announces two new leadership appointments within its Commercial Markets division 2Health News:Blue Cross and Blue Shield of Minnesota announces two new leadership appointments within its Commercial Markets division 3
... http://healthworldnet.com ) receives three Standard of Excellence awards,from ... of,outstanding web sites., The awards were given ... Excellence, and Portal Standard of Excellence. "We are ... CEO of Health,WorldNet, Inc. "The site has only ...
... Medical,Technologies, Inc. (Nasdaq: PMTI ), a leading ... today announced financial,results for the third quarter ended ... 30, 2008 were $24.2 million, of which $19.2 ... $1.0 million,were funded development revenues, and $1.25 million ...
... Mid-Atlantic Region, ATLANTA, Oct. 30 AmeriCare ( ... the opening of its,latest franchises serving Howard, Montgomery, and ... states in the union, Maryland is in the,top 20 ... Marylanders is over the,age of 60. AmeriCare of Maryland ...
... The American Fertility Association,introduces Manicures and Martinis, a ... together in a casual setting over manicures and,martinis ... fertility. It,s,free, relaxing, fun, and educational. The series ... by leading professionals in the reproductive medical,field, including ...
... China Sky One,Medical, Inc. ("China Sky One Medical" ... fully integrated pharmaceutical company producing over-the-counter,drugs in the ... it,recently obtained production approval from the State Food ... its newly developed drugs., Sodium ferulate by ...
... N.J., Oct. 30 Orchid Cellmark Inc.,(Nasdaq: ORCH ), ... its financial results for the third quarter of,2008., Total ... to $15.6 million for the third quarter of 2007. The ... to a year ago was,largely due to lower revenues in ...
Cached Medicine News:Health News:HealthWorldNet.com Receives Three Excellence Awards 2Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 2Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 3Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 4Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 5Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 6Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 7Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 8Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 9Health News:Caregiving Company AmeriCare Adds Franchise in Maryland 2Health News:The American Fertility Association Announces Plan to Help Young Women Preserve Fertility 2Health News:China Sky One Medical, Inc. Obtains Production Approval for Two New Drugs 2Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 2Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 3Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 4Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 5Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 6Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 7Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 8
(Date:6/29/2015)... technique to increase the flow of blood from the umbilical ... red blood cell levels in preterm infants delivered by cesarean ... of Health. The study, published online in Pediatrics, ... Sharp Mary Birch Hospital for Women and Newborns in ... Loma Linda, California . It was supported by ...
(Date:6/29/2015)... WHITE PLAINS, N.Y. and EWING, ... Pharmaceuticals, Inc.  (Nasdaq: CPXX ) today announced that ... is accelerating a portion of the final payment linked ... injection, Celator,s lead product candidate, for the treatment of ... LLS has moved forward payment of $400,000 originally attached ...
(Date:6/29/2015)... 29, 2015  Axovant Sciences Ltd. (NYSE:  AXON), a ... dementia, today announced the acceptance of two presentations at ... in Washington, D.C. from July ... presented via oral and poster presentations as follows: ... Analysis (Oral Presentation): The Efficacy ...
Breaking Medicine Technology:Umbilical cord 'milking' improves blood flow in preterm infants 2Umbilical cord 'milking' improves blood flow in preterm infants 3The Leukemia & Lymphoma Society Accelerates Milestone Payment Associated with the Phase 3 Study of CPX-351 in High Risk (Secondary) AML 2The Leukemia & Lymphoma Society Accelerates Milestone Payment Associated with the Phase 3 Study of CPX-351 in High Risk (Secondary) AML 3The Leukemia & Lymphoma Society Accelerates Milestone Payment Associated with the Phase 3 Study of CPX-351 in High Risk (Secondary) AML 4The Leukemia & Lymphoma Society Accelerates Milestone Payment Associated with the Phase 3 Study of CPX-351 in High Risk (Secondary) AML 5The Leukemia & Lymphoma Society Accelerates Milestone Payment Associated with the Phase 3 Study of CPX-351 in High Risk (Secondary) AML 6Axovant Sciences to Present RVT-101 Alzheimer's Disease Clinical Data at AAIC 2015 Meeting 2Axovant Sciences to Present RVT-101 Alzheimer's Disease Clinical Data at AAIC 2015 Meeting 3
... Oct. 4 West Pharmaceutical Services, Inc. (NYSE: ... approved an increase of one cent per share in the ... the fourth quarter of 2010. The 6.25% increase is the ... fourth quarter dividend will be paid on November 3, 2010 ...
... Oct. 4 Osseon Therapeutics, Inc., a biomedical device ... patent Notice of Allowance (NOA) for its spinal vertebral ... in 2006, now has two allowed and twelve additional ... others throughout the world for spinal therapies and devices. ...
Cached Medicine Technology:Osseon Receives Second Patent Allowance for Minimally Invasive Vertebral Compression Fracture Treatment Devices 2
... 1-step, hand-held, point-of-care device for the qualitative detection ... The TOX/See device can detect up to ... 3 to 8 minutes and requires only a ... individually packaged to maximize convenience and ease of ...
... TOX/See™ is a 1-step, hand-held, point-of-care device ... metabolites in human urine. The TOX/See device ... commonly abused drugs in 3 to 8 minutes ... Each TOX/See cassette is individually packaged to maximize ...
... TOX/See™ is a 1-step, hand-held, point-of-care device for ... in human urine. The TOX/See device can ... abused drugs in 3 to 8 minutes and ... TOX/See cassette is individually packaged to maximize convenience ...
... TOX/See™ is a 1-step, hand-held, point-of-care device for ... in human urine. The TOX/See device can ... abused drugs in 3 to 8 minutes and ... TOX/See cassette is individually packaged to maximize convenience ...
Medicine Products: